Walleye Trading’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-14,210
Closed -$81.8K 5589
2021
Q2
$93K Buy
+14,210
New +$99.3K ﹤0.01% 4406
2021
Q1
Sell
-74,543
Closed -$760K 5174
2020
Q4
$760K Buy
+74,543
New +$483K ﹤0.01% 2266
2019
Q4
Sell
-25,692
Closed -$147K 4513
2019
Q3
$147K Buy
+25,692
New +$175K ﹤0.01% 3125
2018
Q1
Sell
-16,500
Closed -$236K 4711
2017
Q4
$190 Buy
+16,500
New +$246K ﹤0.01% 3484
2017
Q3
Sell
-4,573
Closed -$110 4488
2017
Q2
$110 Sell
4,573
-35,717
-89% -$783K ﹤0.01% 3498
2017
Q1
$799 Buy
+40,290
New +$899K 0.01% 1830
2016
Q4
Sell
-581
Closed -$16.2K 5065
2016
Q3
$16K Buy
+581
New +$15.4K ﹤0.01% 4267
2016
Q2
Sell
-404
Closed -$14K 5641
2016
Q1
$14K Buy
+404
New +$12.7K ﹤0.01% 4611

Other funds holding PGEN

Walleye Trading's PGEN Position: Q3 2021 in Review

Walleye Trading sold out of Precigen (PGEN) in Q3 2021, closing a stake of 14,210 shares — an estimated $81.8K sold.

Walleye Trading first reported a position in PGEN in Q1 2016 and held it in 8 quarters. The position peaked at $760K in Q4 2020. 172 funds tracked by Wall St. Rank hold PGEN as of Q3 2021.

  • Walleye Trading reported no remaining Precigen position as of Q3 2021 after selling out during the quarter.
  • Walleye Trading sold 14,210 Precigen shares in Q3 2021, an estimated $81.8K.
  • Walleye Trading first reported a position in Precigen in Q1 2016 and held it in 8 quarters.
  • Walleye Trading's Precigen position peaked at $760K in Q4 2020.
  • 172 funds tracked by Wall St. Rank held Precigen as of Q3 2021.

Based on Walleye Trading's 13F filing for Q3 2021, filed 15 Nov 2021.